The Canadian Cancer Society (CCS) is proud to launch a new funding program in support of cancer research across Canada. We recognize that the past year has presented exceptional challenges for everyone. It has also presented CCS Research with an opportunity to review and refresh our purpose through the development of a new research strategy that is still taking shape. While we finalize our direction forward, we want to ensure that we continue to support the recovery of the Canadian cancer research ecosystem.
We do not yet know if Challenge grants will be offered on a regular basis, or whether our established programs – Innovation, Innovation to Impact, and Impact grants – will resume ‘as usual’. In pursuit of Inclusive Excellence, and in alignment with our developing research strategy, we are being thoughtful about how these programs might be revised and refined to fit our evolving mandate. We also need to build resilience into our programs following the unexpected impacts of the COVID-19 pandemic. We will provide clarity as soon as we have more information.
Abstract registrations due: July 28, 2021 Full applications due: September 22, 2021
Results announcement: January 2022
Anticipated start date: January 1, 2022
The Challenge grant program will support cancer research projects across the cancer continuum and across disciplines, with an ultimate goal of solving a problem (i.e. a ‘challenge’) in cancer that will be meaningful to people affected by or at risk of cancer. Whether culminating in outcomes that have immediate impact (such as a tool, therapeutic, program, policy, or practice change), or those that are more long term in scope (such as an important finding relevant to the biology or etiology of cancer that could eventually be applied to improve outcomes), applicants must clearly articulate the anticipated contribution of their proposed project towards solving the identified challenge, as well as an estimated timeline for success.